The opioid crisis represents one of the most devastating public health emergencies, both globally and in the United States. This crisis highlights the urgent need to reevaluate pain treatment, particularly for chronic pain.

Beyond causing immeasurable suffering for individuals and families, opioids strain healthcare systems with the costs of treating addiction and overdose. The economic burden of the opioid crisis on the U.S. healthcare system is estimated at nearly $1.5 trillion annually.

Our company was founded in response to this pressing need. Recognizing the limitations of current pain management strategies and the impact of the opioid crisis, we developed a unique injectable, sustained-release CBD therapeutic delivery system. 

This breakthrough offers an effective, non-opioid alternative for both animal and human pain management. 

Our mission is to eliminate Chronic Pain through pharmaceutical innovation, grounded in science. We aim to:

• Provide safe non-opioid chronic pain management solutions for both animals and humans via a unique drug delivery mechanism.
• Develop and market a wide portfolio of personal care and beauty products to promote a healthier lifestyle.

We remain committed to improving lives by delivering better care across Pharmaceuticals and Wellness sectors.